Scientific article
OA Policy
English

pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation

Published in

Journal of autoimmunity, vol. 67, p. 8-18

Publication date

2016

Abstract

Plasmacytoid dendritic cells (pDCs) exhibit both innate and adaptive functions. In particular they are the main source of type I IFNs and directly impact T cell responses through antigen presentation. We have previously demonstrated that during experimental autoimmune encephalomyelitis (EAE) initiation, myelin-antigen presentation by pDCs is associated with suppressive Treg development and results in attenuated EAE. Here, we show that pDCs transferred during acute disease phase confer recovery from EAE. Clinical improvement is associated with migration of injected pDCs into inflamed CNS and is dependent on the subsequent and selective chemerin-mediated recruitment of endogenous pDCs to the CNS. The protective effect requires pDC pre-loading with myelin antigen, and is associated with the modulation of CNS-infiltrating pDC phenotype and inhibition of CNS encephalitogenic T cells. This study may pave the way for novel pDC-based cell therapies in autoimmune diseases, aiming at specifically modulating pathogenic cells that induce and sustain autoimmune inflammation.

Citation (ISO format)

DURAES, Fernanda V et al. pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation. In: Journal of autoimmunity, 2016, vol. 67, p. 8–18. doi: 10.1016/j.jaut.2015.08.014

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0896-8411
747views
348downloads

Technical informations

Creation

08/10/2015 13:31:00

First validation

08/10/2015 13:31:00

Update

13/10/2025 21:09:33

Status update

14/03/2023 23:53:44

Last indexation

02/11/2026 16:26:33
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated